| Metric | შპს ნეოლაბი | შპს ქრომოსი |
|---|---|---|
| Growth | ||
| Revenue | ₾2.3m₾1.9m | ₾1.8m₾763k |
| Revenue growth | 21.5% | 141.6% |
| Profitability | ||
| EBITDA | -₾632k-₾787k | ₾525k-₾366k |
| EBITDA margin | -26.9%-40.8% | 28.5%-47.9% |
| Net profit | -₾643k-₾834k | ₾537k-₾224k |
| Net margin | -27.4%-43.2% | 29.1%-29.3% |
| Balance sheet | ||
| Total assets | ₾6.3m₾7.9m | ₾2.2m₾1.0m |
| Total equity | ₾6.2m₾7.7m | ₾50k-₾486k |
| ROE | -10.4%-10.8% | 1067.0% |